News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Shaheenah Dawood: Exciting News on Abemaciclib’s Impact on ER+ Breast Cancer at ESMO25
Shaheenah Dawood/LinkedIn
Aug 30, 2025, 21:38

Shaheenah Dawood: Exciting News on Abemaciclib’s Impact on ER+ Breast Cancer at ESMO25

Shaheenah Dawood, Consultant Medical Oncologist at Mediclinic Middle East, shared a post on LinkedIn:

“Wow!

Big news out today – adjuvant abemaciclib improves overall survival in high-risk ER+ breast cancer at ~7 years of follow-up!

I am looking forward to the data at ESMO25.”

Abemaciclib

More posts featuring Shaheenah Dawood on OncoDaily

Abemaciclib Breast Cancer cancer ESMO25 Mediclinic Middle East OncoDaily Oncology Shaheenah Dawood
Special Coverage
Voices
Aug 30, 2025, 21:38
Shaheenah Dawood: Exciting News on Abemaciclib's Impact on ER+ Breast Cancer at ESMO25
Insight
Aug 30, 2025, 21:36
Raul Cordoba Shared Key ASCO Recommendations for Geriatric Oncology
Voices
Aug 30, 2025, 21:24
Gustave Roussy Prize: €200,000 Award for Cancer Researcher Applications Open
Voices
Aug 30, 2025, 21:14
George Kumar: How Cancer Cells Change Their Identity Under Pressure
Blog Posts
Aug 30, 2025, 20:56
Welcoming 2 New Teammates This Week - The Babak Lab
Blog Posts
Aug 30, 2025, 20:49
Bishal Gyawali: A Month of Outstanding Accomplishments for Laure-Anne Teuwen
Voices
Aug 30, 2025, 20:35
Enrique Soto: ASCO Guidelines Podcast
Science
Aug 30, 2025, 20:32
Jarushka Naidoo: Summarizing a Sea Change in NSCLC
Voices
Aug 30, 2025, 20:24
Udhayvir Grewal: First NANETS-ENETS Webinar on Pancreatic NET Management
Science
Aug 30, 2025, 20:20
Sanam Loghavi: Relapse Patterns in NPM1-Mutated AML After Venetoclax-Based Therapy
Insight
Aug 30, 2025, 20:13
David Heredia: New ESMO 2025 Guidelines on Early and Locally Advanced NSCLC
Blog Posts
Aug 30, 2025, 20:08
International Approach vs Cancer: Petros Grivas in Brazil